POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Massachusetts bill prohibits off-premises patient transfers for medication adjustments without consent

Original title: An Act to protect patients with Alzheimer's, dementia, and other psychiatric illnesses

Last action · December 4, 2025: Accompanied a study order, see S2790Sponsor: Patrick O'Connor

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Facilities are prohibited from transferring residents suffering from Alzheimer's, dementia, or other psychiatric illnesses for medication adjustments without approval from the patient, guardian, or legally responsible person.

Why it matters

The measure establishes new consent requirements for residential care and medical facilities regarding the off-site transport of vulnerable patients for psychiatric or cognitive medication changes.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Residents with Alzheimer's, dementia, or psychiatric illnesses

Patients suffering from these conditions gain protection requiring their or their representative's consent prior to any off-premises transfer for medication adjustments.

Directly affected

Facility operators

Facilities must obtain prior approval from patients, guardians, or legally responsible persons before transferring specified residents off-premises for medication changes.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who must approve an off-premises transfer for medication adjustments?
Approval must be given by the patient, their guardian, or the person legally responsible for the patient.
Which patients are covered by this restriction?
The restriction applies to residents suffering from Alzheimer's, dementia, or other psychiatric illnesses.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

4 actions
  1. Dec 4, 2025Senate
    Accompanied a study order, see S2790
  2. Jun 6, 2025Joint
    Hearing scheduled for 06/11/2025 from 09:00 AM-01:00 PM in A-1
  3. Feb 27, 2025House
    House concurred
  4. Feb 27, 2025SenateCommittee
    Referred to the committee on Public Health

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

cross reference90% confidence

Study Order Companion

The bill accompanied a study order (S2790) as part of its legislative progress.

Connected Entities

Patrick O'Connor
PersonPatrick O'Connor“Primary sponsor of Senate Bill No. 1594”Map →

Sources

Open source document

malegislature.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record